These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 26601070)
41. In the brain of mice, 3-iodothyronamine (T1AM) is converted into 3-iodothyroacetic acid (TA1) and it is included within the signaling network connecting thyroid hormone metabolites with histamine. Laurino A; De Siena G; Saba A; Chiellini G; Landucci E; Zucchi R; Raimondi L Eur J Pharmacol; 2015 Aug; 761():130-4. PubMed ID: 25941083 [TBL] [Abstract][Full Text] [Related]
42. Recovery of 3-Iodothyronamine and Derivatives in Biological Matrixes: Problems and Pitfalls. Lorenzini L; Ghelardoni S; Saba A; Sacripanti G; Chiellini G; Zucchi R Thyroid; 2017 Oct; 27(10):1323-1331. PubMed ID: 28859548 [TBL] [Abstract][Full Text] [Related]
43. Distribution of exogenous [125I]-3-iodothyronamine in mouse in vivo: relationship with trace amine-associated receptors. Chiellini G; Erba P; Carnicelli V; Manfredi C; Frascarelli S; Ghelardoni S; Mariani G; Zucchi R J Endocrinol; 2012 Jun; 213(3):223-30. PubMed ID: 22442117 [TBL] [Abstract][Full Text] [Related]
44. 3-Iodothyronamine reduces insulin secretion in vitro via a mitochondrial mechanism. Lehmphul I; Hoefig CS; Köhrle J Mol Cell Endocrinol; 2018 Jan; 460():219-228. PubMed ID: 28754352 [TBL] [Abstract][Full Text] [Related]
45. Vasoconstrictor Effects of Trace Amine-Associated Receptor Agonists in the Isolated Perfused Rat Kidney. Jragh D; Yousif MHM; Oriowo MA Med Princ Pract; 2024; 33(6):537-544. PubMed ID: 39047696 [TBL] [Abstract][Full Text] [Related]
46. Comparative Transcriptome Analysis Reveals the Potential Cardiovascular Protective Targets of the Thyroid Hormone Metabolite 3-Iodothyronamine (3-T1AM). Haiyan Z; Bailong H; Bei Z; Yiming W; Xingde L Biomed Res Int; 2020; 2020():1302453. PubMed ID: 32685439 [TBL] [Abstract][Full Text] [Related]
47. Exogenous 3-Iodothyronamine (T Bandini L; Sacripanti G; Borsò M; Tartaria M; Fogliaro MP; Giannini G; Carnicelli V; Figuccia ME; Verlotta S; De Antoni F; Zucchi R; Ghelardoni S Life (Basel); 2022 Aug; 12(9):. PubMed ID: 36143389 [TBL] [Abstract][Full Text] [Related]
48. Evidence for coexistence of three beta-adrenoceptor subtypes in human peripheral lymphocytes. Yu XY; Lin SG; Wang XM; Liu Y; Zhang B; Lin QX; Yang M; Zhou SF Clin Pharmacol Ther; 2007 May; 81(5):654-8. PubMed ID: 17361123 [TBL] [Abstract][Full Text] [Related]
49. Thyroxine metabolite-derived 3-iodothyronamine (T1AM) and synthetic analogs as efficient suppressors of transthyretin amyloidosis. Kim B; Ko YH; Si J; Na J; Ortore G; Chiellini G; Kim JH Comput Struct Biotechnol J; 2023; 21():4717-4728. PubMed ID: 37822560 [TBL] [Abstract][Full Text] [Related]
50. Pharmacogenetics of the human beta-adrenergic receptors. Taylor MR Pharmacogenomics J; 2007 Feb; 7(1):29-37. PubMed ID: 16636683 [TBL] [Abstract][Full Text] [Related]
52. Redox Properties of 3-Iodothyronamine (T1AM) and 3-Iodothyroacetic Acid (TA1). Gencarelli M; Lodovici M; Bellusci L; Raimondi L; Laurino A Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269859 [TBL] [Abstract][Full Text] [Related]
53. TRPM8 Activation via 3-Iodothyronamine Blunts VEGF-Induced Transactivation of TRPV1 in Human Uveal Melanoma Cells. Walcher L; Budde C; Böhm A; Reinach PS; Dhandapani P; Ljubojevic N; Schweiger MW; von der Waydbrink H; Reimers I; Köhrle J; Mergler S Front Pharmacol; 2018; 9():1234. PubMed ID: 30483120 [TBL] [Abstract][Full Text] [Related]
54. Metabolic Suppression by 3-Iodothyronamine Induced Muscle Cell Atrophy via Activation of FoxO-Proteasome Signaling and Downregulation of Akt1-S6K Signaling. Ju H; Kim T; Chung CM; Park J; Nikawa T; Park K; Choi I Biol Pharm Bull; 2017 May; 40(5):576-582. PubMed ID: 28163294 [TBL] [Abstract][Full Text] [Related]
55. Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function. Chiellini G; Frascarelli S; Ghelardoni S; Carnicelli V; Tobias SC; DeBarber A; Brogioni S; Ronca-Testoni S; Cerbai E; Grandy DK; Scanlan TS; Zucchi R FASEB J; 2007 May; 21(7):1597-608. PubMed ID: 17284482 [TBL] [Abstract][Full Text] [Related]
56. Hit-to-Lead Optimization of Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists with a Diphenylmethane-Scaffold: Design, Synthesis, and Biological Study. Chiellini G; Nesi G; Sestito S; Chiarugi S; Runfola M; Espinoza S; Sabatini M; Bellusci L; Laurino A; Cichero E; Gainetdinov RR; Fossa P; Raimondi L; Zucchi R; Rapposelli S J Med Chem; 2016 Nov; 59(21):9825-9836. PubMed ID: 27731647 [TBL] [Abstract][Full Text] [Related]
57. Uptake of 3-iodothyronamine hormone analogs inhibits the growth and viability of cancer cells. Rogowski M; Gollahon L; Chellini G; Assadi-Porter FM FEBS Open Bio; 2017 Apr; 7(4):587-601. PubMed ID: 28396842 [TBL] [Abstract][Full Text] [Related]
58. ADRB1 and ADBR2 gene polymorphisms and the ocular hypotensive response to topical betaxolol in healthy Mexican subjects. Messina Baas O; Pacheco Cuellar G; Toral-López J; Lara Huerta SF; Gonzalez-Huerta LM; Urueta-Cuellar H; Rivera-Vega MR; Babayan-Mena I; Cuevas-Covarrubias SA Curr Eye Res; 2014 Nov; 39(11):1076-80. PubMed ID: 24749907 [TBL] [Abstract][Full Text] [Related]
59. Stimulation of the ADRB3 adrenergic receptor induces relaxation of human placental arteries: influence of preeclampsia. Rouget C; Barthez O; Goirand F; Leroy MJ; Breuiller-Fouché M; Rakotoniaina Z; Guérard P; Morcillo EJ; Advenier C; Sagot P; Cabrol D; Dumas M; Bardou M Biol Reprod; 2006 Jan; 74(1):209-16. PubMed ID: 16177222 [TBL] [Abstract][Full Text] [Related]
60. Modulation of gene expression by 3-iodothyronamine: genetic evidence for a lipolytic pattern. Mariotti V; Melissari E; Iofrida C; Righi M; Di Russo M; Donzelli R; Saba A; Frascarelli S; Chiellini G; Zucchi R; Pellegrini S PLoS One; 2014; 9(11):e106923. PubMed ID: 25379707 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]